{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:50:31Z","timestamp":1789732231388,"version":"4.0.1"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,4,15]]},"DOI":"10.2146\/ajhp150395","type":"journal-article","created":{"date-parts":[[2016,4,4]],"date-time":"2016-04-04T10:13:12Z","timestamp":1459764792000},"page":"556-561","source":"Crossref","is-referenced-by-count":7,"title":["Novel plasminogen and hyaluronate sodium eye drop formulation for a patient with ligneous conjunctivitis"],"prefix":"10.1093","volume":"73","author":[{"given":"Franca Manganelli","family":"Conforti","sequence":"first","affiliation":[{"name":"Healthcare Department, Research Institute, Bambino Ges\u00fa Children\u2019s Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovina","family":"Di Felice","sequence":"additional","affiliation":[{"name":"Laboratory Department, Research Institute, Bambino Ges\u00fa Children\u2019s Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bernaschi","sequence":"additional","affiliation":[{"name":"Laboratory Department, Research Institute, Bambino Ges\u00fa Children\u2019s Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Bartuli","sequence":"additional","affiliation":[{"name":"Pediatrics Medicine Department, Research Institute, Bambino Ges\u00fa Children\u2019s Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Bianco","sequence":"additional","affiliation":[{"name":"Healthcare Department, Research Institute, Bambino Ges\u00fa Children\u2019s Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Simonetti","sequence":"additional","affiliation":[{"name":"University-Hospital Pediatric Department, Research Institute, Bambino Ges\u00fa Children\u2019s Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Buzzonetti","sequence":"additional","affiliation":[{"name":"Department of Surgery, Research Institute, Bambino Ges\u00fa Children\u2019s Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Valente","sequence":"additional","affiliation":[{"name":"Department of Surgery, Research Institute, Bambino Ges\u00fa Children\u2019s Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Corsetti","sequence":"additional","affiliation":[{"name":"Healthcare Department, Research Institute, Bambino Ges\u00fa Children\u2019s Hospital, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t2019041102523137800_b1-0730556","unstructured":"Committee for Orphan Medicinal Products, European Medicines Agency. Public summary of positive opinion for orphan designation of human plasminogen for the treatment of ligneous conjunctivitis (January16, 2008). www.ema.europa.eu\/docs\/en_GB\/document_library\/Orphan_designation\/2009\/10\/WC500006465.pdf (accessed 2015 May 19)."},{"key":"key\n\t\t\t\t2019041102523137800_b2-0730556","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1056\/NEJM199812033392305","article-title":"Therapy with a purified plasminogen concentrate in an infant with ligneous conjunctivitis and homozygous plasminogen deficiency","volume":"339","author":"Schott","year":"1998","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041102523137800_b3-0730556","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0268-9499(96)80021-X","article-title":"Plasminogen activators in human corneal fibroblasts: secretion, cellular localization, and regulation","volume":"10","author":"Mirshahi","year":"1996","journal-title":"Fibrinolysis"},{"key":"key\n\t\t\t\t2019041102523137800_b4-0730556","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/00003226-200311000-00009","article-title":"Treatment of ligneous conjunctivitis with topical plasmin and topical plasminogen","volume":"22","author":"Heidemann","year":"2003","journal-title":"Cornea"},{"key":"key\n\t\t\t\t2019041102523137800_b5-0730556","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1016\/S0161-6420(00)00210-4","article-title":"A new approach to stage 3 macular holes","volume":"107","author":"Trese","year":"2000","journal-title":"Ophthalmology"},{"key":"key\n\t\t\t\t2019041102523137800_b6-0730556","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0002-9394(01)01433-7","article-title":"Effective treatment of ligneous conjunctivitis with topical plasminogen","volume":"133","author":"Watts","year":"2002","journal-title":"Am J Ophthalmol"},{"key":"key\n\t\t\t\t2019041102523137800_b7-0730556","unstructured":"Committee for Proprietary Medicinal Products, European Medicines Agency. Note for guidance on maximum shelf-life for sterile products for human use after first opening or following reconstitution (January28, 1998). www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2009\/09\/WC500003476.pdf (accessed 2015 Sep 12)."},{"key":"key\n\t\t\t\t2019041102523137800_b8-0730556","volume-title":"Human concentrated plasminogen package insert","year":"2014"},{"key":"key\n\t\t\t\t2019041102523137800_b9-0730556","volume-title":"Biolon (hyaluronate sodium) package insert","year":"2014"},{"key":"key\n\t\t\t\t2019041102523137800_b10-0730556","unstructured":"World Health Organization. Development of paediatric medicines: points to consider in formulation (October2011). http:\/\/apps.who.int\/medicinedocs\/documents\/s19464en\/s19464en.pdf (accessed 2015 May 17)."},{"key":"key\n\t\t\t\t2019041102523137800_b11-0730556","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: the good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"key\n\t\t\t\t2019041102523137800_b12-0730556","article-title":"Hyaluronan [monograph]","volume-title":"Drug-Bank, version 4.2 [online database]"},{"key":"key\n\t\t\t\t2019041102523137800_b13-0730556","article-title":"Hyaluronic acid [monograph]","volume-title":"TOXNET Toxicology Data Network [online database]"},{"key":"key\n\t\t\t\t2019041102523137800_b14-0730556","first-page":"494","article-title":"Ophthalmic dosage forms","volume-title":"Principi di tecnologie farmaceutiche","author":"Burgalassi","year":"2004","edition":"1st ed"},{"key":"key\n\t\t\t\t2019041102523137800_b15-0730556","volume-title":"Dropstar (sodium hyaluronate) package insert","year":"2014"},{"key":"key\n\t\t\t\t2019041102523137800_b16-0730556","unstructured":"World Health Organization. International pharmacopoeia (2014). http:\/\/apps.who.int\/phint\/en\/p\/docf\/ (accessed 2015 May 18)."}],"container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/73\/8\/556\/28335174\/ajhp0556.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T07:05:07Z","timestamp":1567753507000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/73\/8\/556\/5101671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,15]]},"references-count":16,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,4,15]]}},"URL":"https:\/\/doi.org\/10.2146\/ajhp150395","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2016,4,15]]},"published":{"date-parts":[[2016,4,15]]}}}